FCPM III SERVICES B.V. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, FCPM III SERVICES B.V. held in its portfolio 10 assets valued at $762,886,865 (i.e. $762.89M).

The most valuable assets in the portfolio included: NEWAMSTERDAM PHARMA COMPANY ($322.70M), DYNE THERAPEUTICS INC ($106.85M), and ENGENE HOLDINGS INC ($86.98M).

The chart below shows the top 10 valuable assets, and the table below shows the top 10 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in FCPM III SERVICES B.V. Portfolio

NEWAMSTERDAM PHARMA COMPANY

DYNE THERAPEUTICS INC

ENGENE HOLDINGS INC

RAPT THERAPEUTICS INC

MAPLIGHT THERAPEUTICS INC

VOR BIOPHARMA INC

REPLIMUNE GROUP INC

BICYCLE THERAPEUTICS PLC

CRESCENT BIOPHARMA INC.

ENGENE HOLDINGS INC

FCPM III SERVICES B.V. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
NEWAMSTERDAM PHARMA COMPANY	9198900	322697412	ORDINARY SHARES
DYNE THERAPEUTICS INC	5462846	106853268	COM
ENGENE HOLDINGS INC	9632561	86982026	COM
RAPT THERAPEUTICS INC	1833333	62094989	COM NEW
MAPLIGHT THERAPEUTICS INC	3226400	56671716	COM
VOR BIOPHARMA INC	3617354	47314990	COM NEW
REPLIMUNE GROUP INC	2808368	27297337	COM
BICYCLE THERAPEUTICS PLC	3468430	24556484	SPONSORED ADS
CRESCENT BIOPHARMA INC.	1677852	19899325	COM
ENGENE HOLDINGS INC	2878148	8519318	W EXP 10/31/2028